Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Takeda Pharmaceutical - 17 Year Stock Price History | TAK

Historical daily share price chart and data for Takeda Pharmaceutical since 2008 adjusted for splits and dividends. The latest closing stock price for Takeda Pharmaceutical as of May 09, 2025 is 14.36.
  • The all-time high Takeda Pharmaceutical stock closing price was 22.30 on January 26, 2018.
  • The Takeda Pharmaceutical 52-week high stock price is 15.43, which is 7.5% above the current share price.
  • The Takeda Pharmaceutical 52-week low stock price is 12.57, which is 12.5% below the current share price.
  • The average Takeda Pharmaceutical stock price for the last 52 weeks is 13.96.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Takeda Pharmaceutical Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 14.2626 13.2500 15.3800 12.8900 14.3600 8.46%
2024 13.6137 13.7190 14.7347 12.3115 13.2400 -3.02%
2023 14.5205 14.4978 16.0415 12.7814 13.6520 -4.87%
2022 12.7833 12.1636 14.3690 11.4253 14.3506 19.37%
2021 14.1561 15.1651 16.7751 11.6167 12.0224 -21.64%
2020 14.8382 16.1150 16.4305 10.5330 15.3421 -3.88%
2019 14.7968 12.9536 16.8512 12.8335 15.9613 23.22%
2018 16.5648 20.7190 22.2969 12.0448 12.9536 -37.24%
2017 18.0691 14.2384 20.7190 14.0810 20.6392 45.13%
2016 15.0944 15.8917 16.5900 13.6953 14.2213 -11.83%
2015 15.4591 12.5986 16.7310 12.5986 16.1301 27.59%
2014 13.3497 13.3262 14.2188 12.5163 12.6424 -5.61%
2013 13.9141 12.6803 15.8190 12.4884 13.3931 7.38%
2012 12.2353 11.9341 13.2194 11.0549 12.4724 5.51%
2011 12.1815 12.6660 12.8304 10.5509 11.8215 -5.48%
2010 11.1604 10.0940 12.5325 9.9542 12.5068 26.38%
2009 9.4494 12.2829 12.2829 7.0287 9.8965 -16.61%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $45.692B $30.087B
Takeda Pharmaceutical Company Limited operates as a research-based pharmaceutical company, engaged in manufacturing, marketing, and importing/exporting pharmaceutical drugs. Takeda's core business comprise of ethical drugs and its portfolio includes lansoprazole for the treatment of peptic ulcers, leuprolide acetate for the treatment of prostate cancer and endometriosis, pioglitazone hydrocholoride for the treatment of diabetes, and candesartan cilexetil for the treatment of hypertension. The Company promotes enhancing R&D pipeline, while concentrating its management resources to the four core therapeutic areas: lifestyle-related diseases, oncology and urological diseases, central nervous system disease and gastroenterological diseases. It operates in two segments- Ethical drug business and Consumer healthcare business. Consumer healthcare business provides Alinamin (vitamin B1 derivative preparations, etc.), Benza (cold remedies). Takeda Pharmaceutical Company Limited is headquartered in Osaka, Japan.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $92.840B 34.83
Zoetis (ZTS) United States $70.908B 26.46
Daiichi Sankyo, - (DSNKY) Japan $46.582B 23.70
Sandoz Group AG (SDZNY) Switzerland $20.090B 0.00
Merck (MKKGY) Germany $17.991B 14.89
Summit Therapeutics (SMMT) United States $17.794B 0.00
Shionogi (SGIOY) Japan $14.019B 0.00
United Therapeutics (UTHR) United States $13.596B 12.03
Neurocrine Biosciences (NBIX) United States $11.451B 39.22
IPSEN (IPSEY) France $9.860B 0.00
Orion OYJ (ORINY) Finland $8.661B 23.42
Corcept Therapeutics (CORT) United States $7.448B 60.54
Stevanato Group S.p.A (STVN) Italy $7.268B 44.44
Madrigal Pharmaceuticals (MDGL) United States $6.542B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.976B 0.00
Ionis Pharmaceuticals (IONS) United States $5.134B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.040B 10.32
Grifols, S.A (GRFS) Spain $4.882B 0.00
Soleno Therapeutics (SLNO) United States $3.869B 0.00
Crinetics Pharmaceuticals (CRNX) United States $2.873B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.851B 9.99
Hypermarcas (HYPMY) Brazil $2.486B 16.35
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.297B 12.56
BioCryst Pharmaceuticals (BCRX) United States $2.086B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.017B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.760B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.643B 0.00
Guardian Pharmacy Services (GRDN) United States $1.622B 0.00
Indivior (INDV) United States $1.528B 6.48
Evotec AG (EVO) Germany $1.527B 0.00
ARS Pharmaceuticals (SPRY) United States $1.320B 168.00
Dyne Therapeutics (DYN) United States $1.297B 0.00
Ocular Therapeutix (OCUL) United States $1.125B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.093B 44.44
Collegium Pharmaceutical (COLL) United States $0.928B 5.01
Avadel Pharmaceuticals (AVDL) Ireland $0.907B 0.00
Enliven Therapeutics (ELVN) United States $0.904B 0.00
Harrow (HROW) United States $0.895B 0.00
Ardelyx (ARDX) United States $0.866B 0.00
Xeris Biopharma Holdings (XERS) United States $0.783B 0.00
Cronos Group (CRON) Canada $0.763B 0.00
AleAnna (ANNA) United States $0.732B 0.00
Akebia Therapeutics (AKBA) United States $0.670B 0.00
Xencor (XNCR) United States $0.593B 0.00
KalVista Pharmaceuticals (KALV) United States $0.592B 0.00
USANA Health Sciences (USNA) United States $0.549B 11.94
Bioventus (BVS) United States $0.547B 13.92
Regulus Therapeutics (RGLS) United States $0.545B 0.00
Relay Therapeutics (RLAY) United States $0.514B 0.00
CytoDyn (CYDY) United States $0.497B 0.00
Savara (SVRA) United States $0.494B 0.00
Elite Pharmaceuticals (ELTP) United States $0.469B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.449B 0.00
Altimmune (ALT) United States $0.431B 0.00
Zevra Therapeutics (ZVRA) United States $0.430B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.411B 0.00
Siga Technologies (SIGA) United States $0.404B 8.45
Organogenesis (ORGO) United States $0.388B 0.00
Tourmaline Bio (TRML) United States $0.388B 0.00
Verve Therapeutics (VERV) United States $0.377B 0.00
Oruka Therapeutics (ORKA) United States $0.357B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.335B 9.07
Heron Therapeutics (HRTX) United States $0.322B 0.00
Aquestive Therapeutics (AQST) United States $0.277B 0.00
Nature's Sunshine Products (NATR) United States $0.253B 23.39
ProKidney (PROK) United States $0.211B 0.00
Wellgistics Health (WGRX) United States $0.195B 0.00
Liminatus Pharma (LIMN) $0.194B 0.00
MediWound (MDWD) Israel $0.189B 0.00
Avita Medical (RCEL) United States $0.184B 0.00
OmniAb (OABI) United States $0.176B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.164B 0.00
Nanobiotix S.A (NBTX) France $0.161B 0.00
Journey Medical (DERM) United States $0.159B 0.00
Esperion Therapeutics (ESPR) United States $0.158B 0.00
Inhibikase Therapeutics (IKT) United States $0.149B 0.00
Korro Bio (KRRO) United States $0.146B 0.00
4D Molecular Therapeutics (FDMT) United States $0.143B 0.00
Profound Medical (PROF) Canada $0.139B 0.00
Aclaris Therapeutics (ACRS) United States $0.136B 0.00
Larimar Therapeutics (LRMR) United States $0.136B 0.00
Aldeyra Therapeutics (ALDX) United States $0.131B 0.00
Protara Therapeutics (TARA) United States $0.125B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.121B 0.00
Lyell Immunopharma (LYEL) United States $0.118B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.115B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.112B 0.00
Nektar Therapeutics (NKTR) United States $0.110B 0.00
VAXART, INC (VXRT) United States $0.096B 0.00
OptiNose (OPTN) United States $0.095B 0.00
Cardiol Therapeutics (CRDL) Canada $0.095B 0.00
Lexeo Therapeutics (LXEO) United States $0.089B 0.00
Dominari Holdings (DOMH) United States $0.088B 0.00
Galectin Therapeutics (GALT) United States $0.087B 0.00
Champions Oncology (CSBR) United States $0.086B 14.14
Cassava Sciences (SAVA) United States $0.086B 0.00
Arch Biopartners (ACHFF) Canada $0.082B 0.00
Achieve Life Sciences (ACHV) Canada $0.082B 0.00
Fractyl Health (GUTS) United States $0.079B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.079B 0.00
ESSA Pharma (EPIX) Canada $0.076B 0.00
Telomir Pharmaceuticals (TELO) United States $0.074B 0.00
Context Therapeutics (CNTX) United States $0.070B 0.00
Inotiv (NOTV) United States $0.067B 0.00
Unicycive Therapeutics (UNCY) United States $0.066B 0.00
Pyxis Oncology (PYXS) United States $0.066B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.066B 52.22
Nutriband (NTRB) United States $0.064B 0.00
Vivani Medical (VANI) United States $0.062B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Assertio Holdings (ASRT) United States $0.058B 0.00
Gain Therapeutics (GANX) United States $0.057B 0.00
Metagenomi (MGX) United States $0.056B 0.00
Karyopharm Therapeutics (KPTI) United States $0.052B 0.00
Century Therapeutics (IPSC) United States $0.046B 0.00
PMV Pharmaceuticals (PMVP) United States $0.046B 0.00
Mural Oncology (MURA) Ireland $0.045B 0.00
Avalo Therapeutics (AVTX) United States $0.044B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.041B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.038B 0.00
SCYNEXIS (SCYX) United States $0.037B 0.00
Iterum Therapeutics (ITRM) Ireland $0.036B 0.00
Acrivon Therapeutics (ACRV) United States $0.036B 0.00
Rafael Holdings (RFL) United States $0.036B 0.00
NRx Pharmaceuticals (NRXP) United States $0.035B 0.00
ElectroCore (ECOR) United States $0.035B 0.00
Prelude Therapeutics (PRLD) United States $0.034B 0.00
FibroGen (FGEN) United States $0.031B 0.00
PolyPid (PYPD) Israel $0.028B 0.00
Surrozen (SRZN) United States $0.027B 0.00
Enlivex Therapeutics (ENLV) Israel $0.024B 0.00
Tempest Therapeutics (TPST) United States $0.024B 0.00
CASI Pharmaceuticals (CASI) China $0.023B 0.00
DURECT (DRRX) United States $0.023B 0.00
Mannatech (MTEX) United States $0.021B 8.31
BioVie (BIVI) United States $0.021B 0.00
Jupiter Neurosciences (JUNS) United States $0.021B 0.00
Natural Alternatives (NAII) United States $0.020B 0.00
VYNE Therapeutics (VYNE) United States $0.020B 0.00
Vivos Therapeutics (VVOS) United States $0.018B 0.00
Lipocine (LPCN) United States $0.018B 0.00
TherapeuticsMD (TXMD) United States $0.017B 0.00
GlycoMimetics (GLYC) United States $0.016B 0.00
Relmada Therapeutics (RLMD) United States $0.014B 0.00
MEI Pharma (MEIP) United States $0.014B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.013B 0.00
ProPhase Labs (PRPH) United States $0.013B 0.00
Ernexa Therapeutics (ERNA) United States $0.012B 0.00
Scienture Holdings (SCNX) United States $0.012B 0.00
Cosmos Health (COSM) United States $0.011B 0.00
Minerva Neurosciences (NERV) United States $0.011B 8.47
Plus Therapeutics (PSTV) United States $0.011B 0.00
Talphera (TLPH) United States $0.011B 0.00
BioLineRx (BLRX) Israel $0.011B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Mangoceuticals (MGRX) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Phio Pharmaceuticals (PHIO) United States $0.008B 0.00
Ainos (AIMD) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Carisma Therapeutics (CARM) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.008B 0.00
Citius Pharmaceuticals (CTXR) United States $0.007B 0.00
Traws Pharma (TRAW) United States $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
Lyra Therapeutics (LYRA) United States $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.006B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.006B 0.00
Jaguar Animal Health (JAGX) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Klotho Neurosciences (KLTO) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Conduit Pharmaceuticals (CDT) United States $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
PainReform (PRFX) Israel $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Incannex Healthcare (IXHL) Australia $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
SHINECO (SISI) China $0.001B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Heatwurx (PCSA) United States $0.001B 0.00
Petros Pharmaceuticals (PTPI) United States $0.000B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Aditxt (ADTX) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00